EE200200039A - Tiksokortoolpivalaadi suspensioon, sellel põhinevkollutoorium ja seda sisaldav pakend - Google Patents

Tiksokortoolpivalaadi suspensioon, sellel põhinevkollutoorium ja seda sisaldav pakend

Info

Publication number
EE200200039A
EE200200039A EEP200200039A EEP200200039A EE200200039A EE 200200039 A EE200200039 A EE 200200039A EE P200200039 A EEP200200039 A EE P200200039A EE P200200039 A EEP200200039 A EE P200200039A EE 200200039 A EE200200039 A EE 200200039A
Authority
EE
Estonia
Prior art keywords
collutate
packaging
suspension
thixocortol pivalate
pharyngeal
Prior art date
Application number
EEP200200039A
Other languages
English (en)
Estonian (et)
Inventor
Doat Bernard
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of EE200200039A publication Critical patent/EE200200039A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Cartons (AREA)
  • Supplying Of Containers To The Packaging Station (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Polymerisation Methods In General (AREA)
  • Vehicle Body Suspensions (AREA)
  • Wrapping Of Specific Fragile Articles (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP200200039A 1999-07-22 2000-07-07 Tiksokortoolpivalaadi suspensioon, sellel põhinevkollutoorium ja seda sisaldav pakend EE200200039A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9909556A FR2796553B1 (fr) 1999-07-22 1999-07-22 Suspension de tixocortol pivalate, collutoire a base de celle-ci et conditionnement la contenant
PCT/FR2000/001987 WO2001007053A1 (fr) 1999-07-22 2000-07-07 Suspension de tixocortol pivalate, collutoire a base de celle-ci et conditionnement la contenant

Publications (1)

Publication Number Publication Date
EE200200039A true EE200200039A (et) 2003-04-15

Family

ID=9548429

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200039A EE200200039A (et) 1999-07-22 2000-07-07 Tiksokortoolpivalaadi suspensioon, sellel põhinevkollutoorium ja seda sisaldav pakend

Country Status (25)

Country Link
EP (1) EP1200096B1 (cs)
JP (1) JP2003505421A (cs)
KR (1) KR100718211B1 (cs)
AT (1) ATE269088T1 (cs)
AU (1) AU6296700A (cs)
BG (1) BG106358A (cs)
BR (1) BR0012671A (cs)
CA (1) CA2378390C (cs)
CZ (1) CZ2002144A3 (cs)
DE (1) DE60011620T2 (cs)
DK (1) DK1200096T3 (cs)
DZ (1) DZ3207A1 (cs)
EE (1) EE200200039A (cs)
ES (1) ES2219366T3 (cs)
FR (1) FR2796553B1 (cs)
HK (1) HK1046850B (cs)
HU (1) HUP0202055A3 (cs)
IS (1) IS6228A (cs)
MX (1) MXPA02000834A (cs)
NO (1) NO20020252L (cs)
OA (1) OA11993A (cs)
PL (1) PL354100A1 (cs)
PT (1) PT1200096E (cs)
SK (1) SK762002A3 (cs)
WO (1) WO2001007053A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5317512B2 (ja) * 2008-03-31 2013-10-16 小林製薬株式会社 含嗽用組成物
JP5461785B2 (ja) * 2008-03-31 2014-04-02 小林製薬株式会社 繰り返し感染予防用の医薬組成物
JP2013123450A (ja) * 2011-12-13 2013-06-24 Akihiro Sato 金属錯体イオン液を応用した塵肺の療養方法、および、咽頭・気管・気管支の療養方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877781A (en) * 1987-09-30 1989-10-31 Peter G. LaHaye Medical dispenser and preparation for inflamed tissue
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance

Also Published As

Publication number Publication date
FR2796553B1 (fr) 2001-09-28
HK1046850A1 (en) 2003-01-30
WO2001007053A1 (fr) 2001-02-01
CZ2002144A3 (cs) 2002-06-12
MXPA02000834A (es) 2003-07-14
NO20020252D0 (no) 2002-01-17
AU6296700A (en) 2001-02-13
DZ3207A1 (fr) 2001-02-01
CA2378390A1 (en) 2001-02-01
NO20020252L (no) 2002-01-17
BG106358A (bg) 2002-08-30
IS6228A (is) 2002-01-15
EP1200096A1 (fr) 2002-05-02
KR20020012010A (ko) 2002-02-09
KR100718211B1 (ko) 2007-05-15
DK1200096T3 (da) 2004-09-13
HUP0202055A2 (en) 2002-09-28
DE60011620D1 (de) 2004-07-22
DE60011620T2 (de) 2005-07-21
ES2219366T3 (es) 2004-12-01
HK1046850B (zh) 2004-12-31
OA11993A (fr) 2006-04-18
ATE269088T1 (de) 2004-07-15
BR0012671A (pt) 2002-04-09
HUP0202055A3 (en) 2009-03-30
EP1200096B1 (fr) 2004-06-16
FR2796553A1 (fr) 2001-01-26
SK762002A3 (en) 2002-08-06
PL354100A1 (en) 2003-12-29
CA2378390C (en) 2008-09-23
PT1200096E (pt) 2004-10-29
JP2003505421A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
BR0010952A (pt) Material de revestimento com uma mistura de ácidos silìcicos e uréia e/ou derivados de uréia
NO20011842D0 (no) Stabile, konsentrerte insulinpreparater for pulmonal avlevering
DE60027606D1 (de) Polyphenolisches protein enthaltende bioadhäsive zusammensetzung
BR9811854B1 (pt) processo de preparação de 3,3-dimetilbutiraldeìdo por oxidação de 3,3-dimetilbutanol.
DK0702896T3 (da) Thixotrope vandige suspensioner af plantebeskyttelsesmidler
FI891570A0 (fi) Menetelmä piroksikaamia sisältävän farmaseuttisen koostumuksen valmistamiseksi
WO2001013902A3 (de) Wirkstoffkombination enthaltend Clonidin und Pramipexol
AU5976494A (en) Oxidising agents
PT882726E (pt) Carbazol-carboxamidas como agonistas 5-ht1f
EP0846463A3 (de) Wirkstoffhaltige Pflaster
HRP20010878B1 (en) Ziprasidone suspension
AU2323095A (en) Lactam derivatives useful for pharmaceutical purposes
EE200200039A (et) Tiksokortoolpivalaadi suspensioon, sellel põhinevkollutoorium ja seda sisaldav pakend
BR9804057A (pt) Aplicação de n-óxidos de aminonitrila como ativadores de alvejamento.
DK1235579T3 (da) Farmaceutiske præparater med indhold af trimegeston
WO2002004481A3 (en) Process to increase protein stability
EA200000963A1 (ru) Офтальмологический раствор, содержащий гликоген
MY118864A (en) Use of oxidation promoting chemicals in the oxidation of oxidizable galactose type of alcohol configuration containing polymer
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
ES2190267T3 (es) Recipiente de plastico que contiene formulaciones de farmacos estabilizadas.
Brecht Ekottarshati
FI20002040A7 (fi) Laite energian siirtoon
DE50009728D1 (de) Mopwaschmittel
EP0471092A4 (en) Triazole compound and insecticide